A clinical evaluation of a novel olive leaf formulation for heart health.

Phase 2

Completed

• Conditions: 24-hour ambulatory blood pressure; Cardiovascular - Hypertension

• Registration Number: ACTRN12613000841774
• Lead Sponsor: The University of Newcastle

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-07-30
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Age 18 to 80 years
Body mass index between 20 and 35kg/m2 (determined at screening/baseline visit)
Systolic blood pressure (130-160mmHg) and/or diastolic blood pressure (85-100mmHg) (determined at screening/baseline visit)
Unlikely to change medication and/or supplementation during the study

Exclusion Criteria

A smoker or currently on nicotine therapy
Currently in antihypertensive medication
Currently on insulin therapy
Pregnant or currently breastfeeding
Unwilling to fast overnight before clinic visits
Unwilling to wear the ambulatory blood pressure monitor and have their blood pressure monitored for 24 hours
Unable to commit to the same time and day of the week for all 6 visits of the study
Unwilling to donate 15mL of blood sample at week 0 (baseline) and at week 6 and week 12 after intervention commencement.
Unwilling to maintain currently dietary and physical activity habits during the study.
Any conditions or medication or dietary supplement that in the opinion of the principal investigator may confound the results of the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified